(Bloomberg) -- Royal Bank of Canada’s head of health-care investment banking in the U.S., Robert Steininger, has left the firm.
Steininger departed the RBC Capital Markets unit in early May, a move confirmed by Elisa Barsotti, a spokeswoman for the Toronto-based bank, who declined to elaborate. Steininger didn’t immediately reply to messages seeking comment.
The exit preceded that of his boss, U.S. investment-banking chief Blair Fleming, who was fired for failing to disclose an improper relationship with an employee. The bank announced his departure, which was unrelated to Steininger’s, on June 4.
Steininger, whose successor has yet to be named, joined RBC in 2014 from Jefferies Group, and previously worked at UBS Group AG. He initially joined RBC as co-head of U.S. health care investment banking but assumed sole responsibilities after his co-head, Kevin Davies, left in 2016.
In 2017, RBC ranked 31st among banks providing advice on health-care deals, according to data compiled by Bloomberg.
©2018 Bloomberg L.P.